GIP: Glucose-dependent Insulinotropic Peptide

NCT00239707 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

NIH

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: GIP
DRUG: Modified GIP
DRUG: Normal Saline

Sponsor

National Institute on Aging (NIA)